Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcription elongation factor A1 pseudogene 2 (TCEA1P2) is a processed pseudogene in the human genome, related to the coding gene "Transcription elongation factor A1" (TCEA1), which encodes a transcriptional elongation factor active in mRNA synthesis. As a pseudogene, TCEA1P2 does not produce a functional protein and is not considered a receptor, enzyme, or druggable molecular target. While some pseudogenes may be transcribed or exert regulatory effects, there is no current evidence for a specific biological or clinical role for TCEA1P2[1]. If your intent is to describe a true molecular target that participates in transcription elongation, you should refer to "Transcription elongation factor A1" (TCEA1), a bona fide transcription factor with a known protein product, biological functions, and molecular pathway roles. If your query is specifically about pseudogenes or their biological relevance, clarify that context.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcription elongation factor A1 pseudogene 2 (TCEA1P2).